Top Doctors 2022
shingrix :: Article Creator FDA Approves Prefilled Vaccine Presentation For Shingrix This new Shingrix vaccine presentation eliminates the need for reconstitution, simplifying the administration process for healthcare professionals. The FDA has approved a new, prefilled syringe option of GSK's Shingrix (Zoster Vaccine Recombinant) for the prevention of shingles (herpes zoster), according to a news release published today. This version simplifies the current shingles vaccine process for healthcare professionals by offering both vaccine components, a lyophilized (powder) antigen and a liquid adjuvant, in one syringe, thus eliminating the need for reconstitution. "The prefilled syringe presentation of GSK's shingles vaccine is good news, providing a convenient method of administration," Brigid Groves, vice president of professional affairs, American Pharmacists Association, said in the news release. "The FDA approval is a pos...
Comments
Post a Comment